Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: TPL efforts

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

SGE1

Rank: President [?]

Points: 26670 [?]

Votes: 187 Score: 3.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: TPL efforts - ignite

in response to

Re: sure you can say it was obvious, but many made the assumption that when - ig

SGE1

posted on Jan 15, 2007 08:23AM

Also please note that Alliacense is only offering licenses for one patent potfolio - the MMP:

http://www.alliacense.com/licensing_overview.aspx

The Flash and SWAT patent portfolios are still "coming soon", as has been the case for what, 6-12 months?

So they only have one thing to license - the MMP. So tell us again how Alliacense new hires are directing all their attention elsewhere....

And if you suggest it is directed for independent TPL enterprizes, please explain how it would be in TPL's best interest to work it under the (shared with PTSC - including any revenues) Alliacense umbrella, as opposed to doing it independently with their (ten times as many?) own team of lawyers.